Aligos Therapeutics (ALGS)
(Delayed Data from NSDQ)
$0.49 USD
-0.05 (-8.49%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $0.48 -0.01 (-1.03%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: AMC |
6/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, Aligos Therapeutics (ALGS) reported earnings of -$0.22 per share, missing the Zacks Consensus Estimate of -$0.19 per share. This reflects a negative earnings surprise of 15.79%. Look out for ALGS's next earnings release on August 06, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year increase of 62.79%.
Earnings History
Price & Consensus
Zacks News for ALGS
AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
ALGS: What are Zacks experts saying now?
Zacks Private Portfolio Services